Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ELMD Stock Forecast 2025-2026
$23.06
Current Price
$197.49M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ELMD Price Targets
+64.8%
To High Target of $38.00
+60.5%
To Median Target of $37.00
+56.1%
To Low Target of $36.00
ELMD Price Momentum
+1.9%
1 Week Change
-1.2%
1 Month Change
+46.2%
1 Year Change
-22.0%
Year-to-Date Change
-35.2%
From 52W High of $35.56
+67.8%
From 52W Low of $13.74
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Electromed (ELMD) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ELMD and similar high-potential opportunities.
Latest ELMD Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, ELMD has a bullish consensus with a median price target of $37.00 (ranging from $36.00 to $38.00). Currently trading at $23.06, the median forecast implies a 60.5% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Kyle Bauser at B. Riley Securities, projecting a 64.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ELMD Analyst Ratings
2
Buy
0
Hold
0
Sell
ELMD Price Target Range
Low
$36.00
Average
$37.00
High
$38.00
Current: $23.06
Latest ELMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ELMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 20, 2025 | B. Riley Securities | Kyle Bauser | Buy | Initiates | $38.00 |
| May 11, 2023 | EF Hutton | Constantine Davides | Buy | Reiterates | $15.00 |
| Feb 16, 2023 | EF Hutton | Constantine Davides | Buy | Maintains | $15.00 |
| Feb 15, 2023 | Lake Street | Brooks O'Neil | Buy | Maintains | $26.00 |
| Dec 28, 2022 | Lake Street | Brooks O'Neil | Buy | Assumes | $20.00 |
| Sep 6, 2022 | EF Hutton | Constantine Davides | Buy | Initiates | $13.50 |
| Aug 5, 2022 | Lake Street | Kyle Bauser | Buy | Initiates | $20.00 |
| Nov 24, 2020 | Northland Capital Markets | Outperform | Initiates | $0.00 | |
| Oct 18, 2019 | Dougherty & Co. | Buy | Initiates | $0.00 |
Electromed Inc. (ELMD) Competitors
The following stocks are similar to Electromed based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Electromed Inc. (ELMD) Financial Data
Electromed Inc. has a market capitalization of $197.49M with a P/E ratio of 30.7x. The company generates $59.63M in trailing twelve-month revenue with a 11.3% profit margin.
Revenue growth is +18.7% quarter-over-quarter, while maintaining an operating margin of +15.6% and return on equity of +16.1%.
Valuation Metrics
Market Cap
$197.49M
Enterprise Value
$181.19M
P/E Ratio
30.7x
PEG Ratio
37.8x
Price/Sales
3.3x
Growth & Margins
Revenue Growth (YoY)
+18.7%
Gross Margin
+77.7%
Operating Margin
+15.6%
Net Margin
+11.3%
EPS Growth
+17.6%
Financial Health
Cash/Price Ratio
+8.2%
Current Ratio
5.1x
Debt/Equity
0.2x
ROE
+16.1%
ROA
+10.9%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Electromed Inc. (ELMD) Business Model
About Electromed Inc.
What They Do
Manufacturer of respiratory therapy medical devices.
Business Model
Electromed Inc. generates revenue by manufacturing and distributing innovative medical devices, particularly focusing on respiratory therapy solutions. The company develops products like the SmartVest Airway Clearance System, which are targeted towards patients with chronic respiratory conditions, thus driving sales through direct consumer purchases and partnerships with healthcare providers.
Additional Information
With a strong emphasis on research and development, Electromed Inc. maintains a competitive advantage in medical technology. The company's strategic partnerships and focus on expanding accessibility to its devices further solidify its position in the respiratory care market.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
174
CEO
Mr. James L. Cunniff
Country
United States
IPO Year
2010
Website
smartvest.comElectromed Inc. (ELMD) Latest News & Analysis
Latest News
Quick Summary
Electromed, Inc. (NYSE American: ELMD) will present at the 15th Annual LD Micro Invitational in New York on April 10, 2025, at 2:30 PM.
Why It Matters
Electromed's participation in the LD Micro Invitational could enhance visibility, attract potential investors, and impact stock performance based on the presentation's reception.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Electromed, Inc. (NYSE American: ELMD) announced a board authorization for a $5 million stock repurchase plan effective March 6, 2025, subject to market conditions.
Why It Matters
Electromed's $5 million stock repurchase signals management's confidence in the company's value, potentially boosting share price and indicating a commitment to returning capital to shareholders.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Electromed, Inc. (NYSE: ELMD) will present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference on March 18, 2025, at 10:30 a.m. ET, with a webcast available.
Why It Matters
Electromed's participation in investor conferences highlights its commitment to transparency and engagement, potentially boosting investor confidence and interest in its growth prospects.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Electromed, Inc. (NYSE:ELMD) will hold its Q2 2025 Earnings Conference Call on February 11, 2025, at 5:00 PM ET, featuring key company executives.
Why It Matters
Electromed's Q2 2025 earnings call signifies key financial insights and strategic updates, influencing market perceptions and investment decisions regarding the company's performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Electromed, Inc. (NYSE: ELMD) reported Q2 FY 2025 net revenue of $16.3 million, an 18.7% increase year-over-year, with operating income rising to $2.5 million, 15.6% of revenue.
Why It Matters
Electromed's 18.7% revenue growth and record operating income signal strong demand and operational efficiency, potentially boosting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Electromed, Inc. (NYSE American: ELMD) will release its Q2 fiscal 2025 financial results on February 11, 2025, after market close, followed by a conference call at 5:00 p.m. ET.
Why It Matters
Electromed's upcoming financial results release and conference call could significantly impact stock performance, informing investors about the company's fiscal health and future prospects.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ELMD Stock
What is Electromed Inc.'s (ELMD) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Electromed Inc. (ELMD) has a median price target of $37.00. The highest price target is $38.00 and the lowest is $36.00.
Is ELMD stock a good investment in 2025?
According to current analyst ratings, ELMD has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $23.06. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ELMD stock?
Wall Street analysts predict ELMD stock could reach $37.00 in the next 12 months. This represents a 60.5% increase from the current price of $23.06. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Electromed Inc.'s business model?
Electromed Inc. generates revenue by manufacturing and distributing innovative medical devices, particularly focusing on respiratory therapy solutions. The company develops products like the SmartVest Airway Clearance System, which are targeted towards patients with chronic respiratory conditions, thus driving sales through direct consumer purchases and partnerships with healthcare providers.
What is the highest forecasted price for ELMD Electromed Inc.?
The highest price target for ELMD is $38.00 from Kyle Bauser at B. Riley Securities, which represents a 64.8% increase from the current price of $23.06.
What is the lowest forecasted price for ELMD Electromed Inc.?
The lowest price target for ELMD is $36.00 from at , which represents a 56.1% increase from the current price of $23.06.
What is the overall ELMD consensus from analysts for Electromed Inc.?
The overall analyst consensus for ELMD is bullish. Out of 4 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $37.00.
How accurate are ELMD stock price projections?
Stock price projections, including those for Electromed Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 2:49 PM UTC